首页> 外国专利> Pharmaceutical Association to treat and / or prevent Myoma and / or endometriosis, use of resveratrol and progesterone, Pharmaceutical composition for Prevention and / or treatment of Myoma and / or endometriosis, medicine for Treatment and / or prevention of Myoma and / or endometriosis, Kit and Method for Treatment and / or Prevention of endometriosis and / or Myoma

Pharmaceutical Association to treat and / or prevent Myoma and / or endometriosis, use of resveratrol and progesterone, Pharmaceutical composition for Prevention and / or treatment of Myoma and / or endometriosis, medicine for Treatment and / or prevention of Myoma and / or endometriosis, Kit and Method for Treatment and / or Prevention of endometriosis and / or Myoma

机译:药物协会治疗和/或预防肌瘤和/或子宫内膜异位,使用白藜芦醇和孕酮,预防和/或治疗肌瘤和/或子宫内膜异位的药物组合物,用于治疗和/或预防肌瘤和子宫内膜异位症,用于治疗和/或预防子宫内膜异位和/或肌瘤的试剂盒和方法

摘要

A combination of Resveratrol with progestogens, and Pharmaceutical compositions containing said and Drug combination, which is useful in the Treatment or prevention of Myoma and / or endometriosis, which provides the reduction of its size and Control of related symptoms. Such a combination May additionally include a component of estrogen.They are also the subject of this request a Treatment method and a kit.reivindicaciu00f3n 3: combination, according to claim 1, characterized by the fact that the Progestogen is one or more between the Drospirenone desogestrel, gestodene, Dienogest, or treatment.Claim 10: combination, according to claim 1, characterized by the fact that estrogen is selected between ethinylestradiol, estradiol, Estradiol Valerate or mixtures thereof.
机译:白藜芦醇与孕激素的组合,以及包含所述和药物组合的药物组合物,其可用于治疗或预防肌瘤和/或子宫内膜异位,从而减小其大小并控制相关症状。 3.根据权利要求1所述的组合物,其特征在于,所述孕激素是一种或多种介于两种或多种之间的事实,所述组合物还可以包括雌激素的成分。 10.根据权利要求1所述的组合,其特征在于,雌激素选自乙炔雌二醇,雌二醇,戊酸雌二醇或其混合物。

著录项

  • 公开/公告号AR082998A1

    专利类型

  • 公开/公告日2013-01-23

    原文格式PDF

  • 申请/专利权人 LIBBS FARMACEUTICA LTDA.;

    申请/专利号AR2011P103364

  • 发明设计人 DA SILVA MAIA FILHO HUGO;

    申请日2011-09-15

  • 分类号A61K31/045;A61K31/565;A61K31/57;A61P15;A61P35;

  • 国家 AR

  • 入库时间 2022-08-21 16:42:31

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号